Transgene Biotek Board Meeting Scheduled for August 7

Board Meeting Details

Meeting Date: Friday, August 07, 2026

Agenda Items

1. To consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2026

2. To consider and approve the Limited Review Report (Standalone & Consolidated) of the Company for the quarter ended 30th June 2026

3. To consider and approve seeking an extension of time for holding the Annual General Meeting (AGM) of the Company for the Financial Year 2025-26

4. To consider and approve the appointment of the internal auditor of the Company for financial year 2026-27

5. To transact such other business as may be required

Trading Window Closure Information

The Trading Window for dealing in the securities of the Company was closed from July 1, 2026, and will remain closed until 48 hours after the financial results of the Company for the quarter ended June 30, 2026 become generally available information. This closure is in accordance with the Company's Code of Conduct adopted pursuant to the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018.